SAC Capital Advisors’s Thermo Fisher Scientific TMO Stock Holding History

SAC Capital Advisors’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-99,472	Closed	-$12M	–	935
2014 Q1	$12M	Sell	99,472 -142,581	-59%	-$17M	0.06%	365
2013 Q4	$27M	Sell	242,053 -395,998	-62%	-$39.4M	0.16%	169
2013 Q3	$58.8M	Sell	638,051 -78,114	-11%	-$7.06M	0.32%	81
2013 Q2	$60.6M	Buy	+716,165	New	+$59.6M	0.33%	81

Other funds holding TMO

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

SAC Capital Advisors's TMO Position: Q2 2014 in Review

SAC Capital Advisors sold out of Thermo Fisher Scientific (TMO) in Q2 2014, closing a stake of 99,472 shares — an estimated $12M sold.

SAC Capital Advisors first reported a position in TMO in Q2 2013 and held it in 4 quarters. The position peaked at $60.6M in Q2 2013. 911 funds tracked by Wall St. Rank hold TMO as of Q2 2014.

SAC Capital Advisors reported no remaining Thermo Fisher Scientific position as of Q2 2014 after selling out during the quarter.
SAC Capital Advisors sold 99,472 Thermo Fisher Scientific shares in Q2 2014, an estimated $12M.
SAC Capital Advisors first reported a position in Thermo Fisher Scientific in Q2 2013 and held it in 4 quarters.
SAC Capital Advisors's Thermo Fisher Scientific position peaked at $60.6M in Q2 2013.
911 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2014.

Based on SAC Capital Advisors's 13F filing for Q2 2014.